Skip to main content
Equibles
NRIX $26.21 -2.47%
NRIX logo
NRIX · Nurix Therapeutics, Inc.
Track NRIX — free

Use NRIX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NRIX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$26.21 -0.67 (-2.47%) At close · Aug 28
Russell 2000 member Rebalance outlook locked
Market Cap
$2.79B
Shares
103.78M
All earnings calls

Earnings call · FY2024 Q4

Nurix Therapeutics, Inc. (NRIX) Q4 2024 Earnings Call

Concluded Jan 13, 2025
Jan 13, 2025 0 turns
Period
FY2024 Q4
Runtime
—
Sources
3 artifacts
Slides 31 8-K 10-K

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 10-K stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Revenue · derived Q4 $13.28M -12.4% YoY
Net income · derived Q4 -$58.55M

Research materials

Open the source you need; every reader stays inside this workspace.

Presentation 31 slides 8-K earnings release Filed Jan 13, 2025 10-K report Filed Jan 28, 2025 Company webcastOpen the original investor-relations page
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)